Epiminder Ltd. (DUS:1L7) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chip Moebus | VP, Market Access · Since at least Nov 4, 2026 |
| Donal O'Dwyer | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Jeff Sells | Independent Non-Executive Director · Since at least Nov 4, 2026 |
| John Heasman | Chief Operating Officer · Since at least Nov 4, 2026 |
| Mark Cook | Chief Medical Officer · Since at least Nov 4, 2026 |
| Mark McLellan | Chief Financial Officer and Company Secretary · Nov 3, 2026 – Nov 3, 2026 · Past |
| Melita Lambiris | VP, Quality & Regulatory · Since at least Nov 4, 2026 |
| Patricia O'Rourke | Non-Executive Director · Since at least Nov 5, 2026 |
| Philip Binns | Chair · Since at least Nov 4, 2026 |
| Robert Klupacs | Non-Executive Director · Since at least Nov 5, 2026 |
| Rohan Hoare | Chief Executive Officer & Managing Director · Since at least Nov 5, 2026 |
| Steven Ringo | VP, IT & Security · Since at least Nov 4, 2026 |
| Toby McSweeney | Chief Technology Officer · Since at least Nov 4, 2026 |
| Tracy Cameron | VP, Clinical & Regulatory · Since at least Nov 4, 2026 |